Abiopharma

Organon annuncia un accordo per la vendita a Laborie del suo JADA® System per un importo massimo di 465 milioni di dollari

Summit Plc - Current report filing

Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762

CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

STAAR Surgical Announces Amendments to Alcon Merger Agreement

Summit Plc - Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study Conducted by Akeso in China

Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

ATEC - ATEC Mourns Passing of Board Member Jeffrey P. Rydin

ATEC Mourns Passing of Board Member Jeffrey P. Rydin

A New Press Release from Elicio Therapeutics